And don't forget they need reimbursement before they really go hard on the sales launch, the webinar said they've had alot of discussions in the background with those phase 1 accounts, but they didn't say how long after FDA approval it'll take to get them to each sign on the dotted line, there's probably some lag here as well? Anyways all these unknowns is why I'd be abit conservative in the short term.
And don't forget they need reimbursement before they really go...
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.015(4.17%) |
Mkt cap ! $590.6M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 40.0¢ | 36.5¢ | $10.56M | 27.45M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 75348 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 514698 | 3 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |